AI Pipeline Can Accurately Measure Sarcopenia in Head and Neck Cancer
MONDAY, Aug. 14, 2023 (HealthDay News) -- A fully automated deep learning pipeline can accurately measure sarcopenia in head and neck squamous cell carcinoma (HNSCC), which is associated with disease outcomes, according to a study published online Aug. 10 in JAMA Network Open.
Zezhong Ye, Ph.D., from Harvard Medical School in Boston, and colleagues developed and externally validated a fully automated image-based deep learning platform for cervical vertebral muscle segmentation and skeletal muscle index (SMI) calculation. Associations with survival and treatment toxicity outcomes were examined using data for 899 patients with HNSCC undergoing primary radiation with abdominal computed tomography scans and complete clinical information.
The researchers found that the dice similarity coefficients for the validation set and internal test set (96 and 48 participants, respectively) were both 0.90, with a mean 96.2 percent acceptable rate between two reviewers on external clinical testing (377 participants). Across datasets, estimated cross-sectional area and SMI values were associated with manually annotated values. Compared with no sarcopenia, SMI-derived sarcopenia was associated with worse overall survival and longer feeding tube duration (162 versus 134 days).
"If further validated, our end-to-end deep learning pipeline could be incorporated into standard clinical practice for directing future treatment approaches and clinical decision making, as well as for individualized supportive measures, including nutrition guidance and physical therapy," the authors write.
Several authors disclosed ties to the pharmaceutical and biopharmaceutical industries.
Related Posts
En EE. UU., el hambre de los niños se disparó después de que se derogaran los créditos tributarios por hijos
LUNES, 24 de octubre de 2022 (HealthDay News) -- Los créditos tributarios por...
One in Seven Nonelderly Adults Have Past-Due Medical Debt
WEDNESDAY, March 15, 2023 (HealthDay News) -- More than 15 percent of nonelderly...
Dietary ALA Intake Tied to Prognosis in Heart Failure
TUESDAY, Oct. 25, 2022 (HealthDay News) -- For patients with heart failure,...
La vacunación contra la COVID puede ser segura incluso en las personas con alergias graves
MARTES, 26 de octubre de 2021 (HealthDay News) -- Si usted sufre de alergias...